PanGen Biotech Inc. (KOSDAQ:222110)
5,980.00
-60.00 (-0.99%)
At close: Aug 28, 2025
PanGen Biotech Revenue
PanGen Biotech had revenue of 3.49B KRW in the quarter ending June 30, 2025, with 53.70% growth. This brings the company's revenue in the last twelve months to 15.86B, up 42.45% year-over-year. In the year 2024, PanGen Biotech had annual revenue of 14.67B with 100.58% growth.
Revenue (ttm)
15.86B
Revenue Growth
+42.45%
P/S Ratio
5.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
80.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.67B | 7.36B | 100.58% |
Dec 31, 2023 | 7.32B | 814.47M | 12.53% |
Dec 31, 2022 | 6.50B | -1.43B | -18.08% |
Dec 31, 2021 | 7.94B | 1.74B | 28.18% |
Dec 31, 2020 | 6.19B | 3.31B | 114.87% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hyundai Motor Company | 182.25T |
Hanwha Aerospace | 19.25T |
HD Hyundai Heavy Industries | 15.58T |
Doosan Enerbility | 16.30T |